No Conclusions About MS Drug Superiority (CME/CE)

(MedPage Today) -- Two cohort studies give opposing views of natalizumab versus fingolimod efficacy

Source: MedPage Today Neurology - October 9, 2015 Category: Neurology Source Type: news